Ask ten investors what a stock is worth and you will get ten answers. That is not a flaw in the process, it is the process. Valuation is not the search for a single correct number. It is the disciplined narrowing of a range wide enough to be honest and tight enough to be useful -- and then deciding whether the market is offering you a price outside that range.
This guide walks the full sequence: understanding the business, choosing a method that fits it, sourcing inputs you can defend, doing the arithmetic, cross-checking the answer, and deciding what price actually pays you for the risk of being wrong.
Price and value are two different questions
Price is an observed fact. It is printed on the screen, updated every second, and it is the only number in this entire exercise that you do not have to estimate. Value is a judgement about a stream of future cash flows that has not happened yet.
Most investor mistakes come from collapsing the two. A falling price feels like a fact about value, so a stock down 40% is assumed to be cheaper. Sometimes. But price moves with liquidity, index flows, tax-year selling, sentiment and forced liquidation. Value moves with the business. When the two diverge for long enough, you get your opportunity -- or your value trap.
The four families of valuation methods
Almost every method you will encounter belongs to one of four families. They are not competing answers to the same question; they are answers to slightly different questions.
- Discounted cash flow. Project the cash the business produces and discount it back at an appropriate rate. Best for stable, cash-generative businesses. See the DCF calculator and, for dividend payers, the DDM calculator.
- Relative multiples. Compare the price against a fundamental, then against peers. Fast, market-aware, but inherits whatever mispricing is in the peer group. See the P/E calculator, EV/EBITDA calculator and P/B calculator.
- Asset-based. What are the net assets worth, on the books or at replacement cost? Matters most for banks, holding companies and asset-heavy cyclicals.
- Earnings-power rules of thumb. Defensive formulas that encode a required return and a safety margin. The Graham number calculator is the classic example.
Notice that only the first family even attempts to answer "what is this worth". The other three answer "what is this worth relative to something else". Both are useful. Mixing them up is how people end up arguing past each other.
Step 1 -- Understand the business before you touch the numbers
This is the step people skip, and it is the reason most spreadsheets are confident nonsense. Before estimating anything, you need defensible answers to four questions:
- How does it earn money? Not the slogan -- the actual unit economics. Who pays, how much, how often, and what does it cost to serve them?
- What protects the profit? Brand, switching costs, network effects, regulation, scale, or nothing at all. A company with no moat has a growth rate that decays quickly, which changes the terminal value more than anything else in the model.
- What would have to be true for the bear case? If you cannot state the bear case fairly, you do not understand the bull case either.
- Where does the cash go? Reinvestment, dividends, buybacks or acquisitions. This determines whether growth creates value or destroys it -- a company reinvesting at 6% while its cost of capital is 9% grows its way into a smaller valuation.
Step 2 -- Pick a method that fits the company
Method choice is not a matter of taste. It follows from how the business generates cash and how visible that cash is.
| Company type | Method that fits | Why |
|---|---|---|
| Stable, cash-generative, low debt | DCF, or FCF yield | Cash flows are forecastable enough for a discount rate to mean something |
| Mature dividend payer | DDM, two-stage DDM, dividend yield | Cash returned to shareholders is the actual return stream |
| Bank or insurer | P/B paired with ROE | Balance sheet is the business; free cash flow is not meaningful |
| Asset-heavy cyclical | EV/EBITDA, mid-cycle earnings | Earnings swing wildly but operating economics are comparable across peers |
| Pre-profit growth | Revenue multiples, reverse DCF | No earnings to discount, but the price embeds an implied growth rate you can test |
| Holding company | Sum of parts, NAV discount | The value is the assets, not the consolidated cash flow |
If you are unsure, run a reverse DCF first. It flips the model around and tells you what growth rate the current price already assumes. That single number usually tells you more than any forecast you could invent.
Step 3 -- Get the inputs right, because they carry the answer
A DCF has three real inputs. The rest is arithmetic.
Free cash flow. Start from operating cash flow and subtract capital expenditure. Do not use net income as a proxy -- the free cash flow guide walks through why a company can report healthy profits and still burn cash. Use at least five years of history and be suspicious of a single spectacular year.
Growth. Separate the near term from the terminal rate. Near-term growth can be specific: new capacity, a signed contract, a product cycle. Terminal growth cannot exceed long-run nominal GDP, roughly 2-3% in developed markets, because no company permanently outgrows the economy that contains it.
Discount rate. This is your required return, adjusted for the risk of the specific business. Most practitioners start from the WACC -- blended cost of debt and equity. For an all-equity analysis, a simpler framing works better: what return do you need to be compensated for tying up capital here rather than in an index fund?
Then there is the fourth input nobody lists: your confidence. A business with lumpy, contract-driven revenue deserves a wider range than a utility with regulated returns, even if the point estimate is identical.
Step 4 -- A worked example you can follow
Suppose you are looking at Stetron Industries, a fictional industrial supplier.
| Input | Value | Reasoning |
|---|---|---|
| Free cash flow (latest year) | $100m | Five-year average, not the peak year |
| Terminal growth | 4.0% | Slightly above inflation, below nominal GDP plus a real margin |
| Discount rate | 9.0% | Stable margins, modest debt, moderate cyclicality |
| Net debt | $200m | Total debt less cash |
| Shares outstanding | 50m | Fully diluted |
Terminal value, using the Gordon growth form, is the next year's cash flow divided by the spread between the discount rate and growth:
Terminal value = 100 x 1.04 / (0.09 - 0.04) = 104 / 0.05 = $2,080m
Enterprise value is that $2,080m. Deduct net debt to get to the equity, because the debt holders are paid before you:
Equity value = 2,080 - 200 = $1,880m Per share = 1,880 / 50 = $37.60
So the model says $37.60. Now stress it, because a single number is not an answer. Move the discount rate to 8% and you get $2,600m of enterprise value and $48 per share. Move it to 10% and you get $1,733m and $30.66 per share. The growth assumption matters even more: at 3% instead of 4%, with a 9% discount rate, terminal value falls to $1,716m and the per-share answer to $30.32.
Your honest output is not "$37.60". It is something closer to "$30 to $48, most likely low-to-mid thirties, and I am least confident about the growth assumption". That is a far more useful sentence.
Step 5 -- Cross-check with a different family
Run a second method from a different family. If your DCF says $37.60 and the P/E against peer earnings says $55, you have learned something: either the earnings base is cyclically inflated, or your cash flow assumptions are too conservative. You do not average the two. You go back and work out which one is wrong.
Useful cross-checks:
- Earnings yield. Invert the P/E. If $37.60 against $2.60 of earnings is 14.5x, the earnings yield is 6.9%. Is that adequate for this business's risk?
- Reverse DCF. At $37.60, what growth rate does that price imply? If it implies 7% and you think 4% is realistic, the market is more optimistic than you.
- Book value context. P/B of 1.8x is cheap for a 20% ROE and expensive for a 6% one. The DuPont ROE calculator breaks the 20% into margin, turnover and leverage so you can see whether it is repeatable.
Step 6 -- Decide a price, not a thesis
A valuation without a buy price is an opinion. Convert yours into an action threshold using a margin of safety. With a $37.60 central estimate and a 25% required discount, you buy below $28.20. If the market never offers it, you own nothing and that is a legitimate outcome -- there is no rule that says your cash has to be invested today.
Then decide how much to buy. Even a good valuation can be ruined by oversizing. A position size calculator turns "I like this" into "this is 4% of my portfolio and a 30% adverse move costs me 1.2%".
Six mistakes that show up over and over
- Anchoring on the current price. If your model output is suspiciously close to the market price, you probably worked backwards from it.
- Terminal-value denial. For a long-lived business, 60-80% of the DCF value usually sits in the terminal value. Pretending otherwise does not remove the assumption, it just hides it.
- Precision theatre. A value of "$37.6034" communicates false confidence. Round to a range.
- Ignoring the balance sheet. Net debt is real. So is off-balance-sheet obligation, pension deficits and lease commitments.
- Reusing one growth rate forever. Fast growth attracts competition. Most high-growth businesses converge to something boring faster than the model assumes.
- Confusing a good company with a good investment. Excellent businesses at excessive prices have produced mediocre returns for long stretches. The price you pay is part of the return.
How long this should take
For a first pass on a familiar company, an experienced investor can get to a defensible range in about ninety minutes: twenty minutes reading the accounts, twenty building the cash flow base, twenty on the assumptions, and thirty stress-testing. Deeper work on a cyclical or a financial is slower because the normalisation stage is harder.
What matters is not speed. It is whether you could explain every input to someone who disagrees with you -- and whether you would still hold the position if the price fell 30% without any news. If the answer to the second question is no, the valuation was never the real reason you bought.
Where to go next
- DCF calculator -- build the five-year model with a terminal value
- Reverse DCF calculator -- extract the growth rate the market is assuming
- Free cash flow explained -- get the cash flow base right first
- Margin of safety explained -- turn a valuation into a buy price
- WACC calculator -- build a defensible discount rate
- P/E calculator -- the fastest relative cross-check
Frequently asked questions
What is the most accurate way to value a stock?
There is no single most accurate method, and looking for one is itself the mistake. Accuracy comes from how testable your assumptions are, not from which formula you pick. Run the same discounted cash flow on our worked example twice: with five years of flat 4% growth it returns $37.60 a share; with a fading path of 8%, 7%, 6%, 5%, 4% it returns $41.55. The method did not change and the answer moved 10%. Before trusting any number, ask which single assumption would have to be wrong for the conclusion to flip -- the DCF method guide works through that test in full.
Can the same stock be worth different amounts to two different investors?
Yes, and it should be. The discount rate is your opportunity cost, not a property of the company. Take the fading cash flows from our example: at a 9% discount rate they support $41.55 a share, at 10% they support $33.93, and at 12% only $24.40. The market price sits at $37.60, inside all three, which is exactly why it cannot tell you who is right. An investor who requires 12% and one who accepts 9% are not disagreeing about the company -- they are disagreeing about themselves. Where the rate comes from is covered in the WACC guide.
How many valuation methods should you use?
At least two, from different families, and the disagreement is the useful part. A DCF plus one relative multiple is enough. On the worked example, the DCF on a fading path says $41.55 while the Graham number says $27.58 -- a 34% gap. That gap is not something to average away. It is information: the DCF is pricing returns on capital, the Graham formula is pricing the balance sheet. When two methods agree, check that they are not agreeing for the same wrong reason.
What is the biggest mistake people make when valuing a stock?
Treating an assumption as a fact. The most common instance is terminal growth. On our example, moving perpetual growth from 4% to 5% lifts the value from $41.55 to $51.02 and pushes the share of value sitting in the terminal period from 79% to 83%. Nearly the whole valuation now rests on a growth rate nobody can verify, extended forever. A close second is a discount rate below the cost of the money funding the position -- the reverse DCF calculator will show you what growth rate today's price is already assuming, which is usually the fastest way to spot the problem.
Related guides
- Margin of Safety — How big a discount a given business deserves, and why a low multiple is not the same as a discount
- Intrinsic Value vs Market Price — Why the two diverge, when cheap is not cheap, and what should force your estimate downward
- WACC Explained — The discount rate built from five sourced inputs, on the same worked example
More guides
- Free Cash Flow: What It Is and Why It Matters — The input every valuation depends on, including a case where profit is positive and cash flow is not
- Dividend Investing — Testing whether a dividend is actually safe, using payout, cash coverage and leverage
- How to Read a Cash Flow Statement — The three sections, the eight sign combinations, and what each one warns you about
- How to Read a Balance Sheet — Reading the asset side properly: six ratios, the ROE decomposition, and four common traps
- What Is a Good P/E Ratio? — The arithmetic of a justified multiple, and the four ways a low P/E ratio lies to you
- Dividend Yield vs Total Return — Four ten-year scenarios showing why a high yield and a high return are different things
- How to Compare Two Stocks — A five-axis comparison, worked side by side, and why the cheaper multiple can be the dearer stock
- The DCF Method Explained — The forecast half of the model, worked end to end on one cash flow
- The Graham Number Explained — Graham's ceiling tested on two companies, and the three things it cannot see
Free valuation calculators
- DCF Calculator — fair value from five years of cash flow plus terminal value
- Dividend Discount Model — Gordon Growth valuation for dividend payers
- CAGR Calculator — compound growth rate and forward projections
- Dividend Yield Calculator — yield, income per $10,000, capital needed
- Payout Ratio Calculator — dividend safety and sustainable growth
- P/E Ratio Calculator — multiple, earnings yield, PEG, target price
- Graham Number Calculator — Graham's maximum buy price
- Total Return Calculator — price change plus dividends, annualized
- EV/EBITDA Calculator — enterprise value against operating earnings
- WACC Calculator — weighted average cost of capital for discounting
- Two-Stage DDM Calculator — high-growth then stable dividend valuation
- EPS Calculator — basic and diluted earnings per share
- P/B Ratio Calculator — price against book value, with ROE context
- Margin of Safety Calculator — discount between value and price
- Compound Interest Calculator — future value with periodic contributions
- Reverse DCF Calculator — the growth rate today's price already assumes
- DuPont ROE Calculator — break return on equity into its three drivers
- Position Size Calculator — how many shares to buy for a set risk